AR 2007 Lo Res.pdf Barr now operates in over 30 countries across the world.
AR 2007 Lo Res.pdf page 10
CDER: Previous News Items 2003 FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER - Search - Previous News Items 2003 Previous News Items 2004 Previous News Items 2002 December 30, 2003 The prescribing information for Topamax (topiramate/topiramate capsules) has been revised to include a warning that Topamax causes hyperchloremic, non-anion gap metabolic acidosis (decreased serum...
Paragraph IV Patent Certifications - DRUG NAME DOSAGE FORM STRENGTH RLD Acetaminophen Extended-release Tablets 650 mg Tylenol Acetaminophen/ Aspirin/ Caffeine Tablets 250 mg/250 mg/ 65 mg Excedrin (migraine) Acetaminophen and Tramadol Hydrochloride Tablets 325 mg/ 37.5 mg Ultracet Acyclovir Sodium1 Injection 50 mg/mL, 10 mL and 20 mL vials Zovirax Albuterol Sulfate Oral Syrup 2 mg(base)/ 5 mL Ventolin Albuterol...
http://www.fda.gov/cder/orange/appendix_a.txt 4, ACETAMINOPHEN TYLENOL W/ CODEINE, ACETAMINOPHEN TYLENOL, ACETAMINOPHEN (OTC) TYLOX, ACETAMINOPHEN TYLOX-325, ACETAMINOPHEN TYMTRAN, CERULETIDE DIETHYLAMINE TYZINE, TETRAHYDROZOLINE HYDROCHLORIDE TZ-3, TIOCONAZOLE (OTC) ** U ** U-CORT, HYDROCORTISONE ACETATE U-GENCIN, GENTAMICIN SULFATE UCEPHAN, SODIUM BENZOATE ULO, CHLOPHEDIANOL HYDROCHLORIDE ULTANE, SEVOFLURANE ULTIVA,...
NDA Approvals for Calendar Year 2003 NDA APPROVALS FOR CALENDAR YEAR 2003 Updated through December 31, 2003 NDA NUMBER DRUG NAME GENERIC NAME APPLICANT/ SPONSOR CHEMICAL TYPE THERAPEUTIC CLASS APPROVAL DATE - 21434 Xanax XR Alprazolam Pharmacia and Upjohn FR 3 S 17-Jan-03 21305 Sodium Iodide I-131 Sodium Iodide I-131 DraxImage 3,5 S 24-Jan-03 20414 Pyridostigmine Bromide Pyridostigmine Bromide US Army...
author: Susan Daugherty
Drug Approvals - X Product Name Company Application # Approval Date Letter Posted Label Posted Review Posted Xalatan (latanoprost) ophthalmic solution, 0.005%,- Pharmacia & Upjohn Company NDA 20-597/S28 & S29 7/14/03 7/28/03 Xalatan (latanoprost) ophthalmic solution, 0.005%,- Pharmacia & Upjohn Company NDA 20-597/S-025 8/26/02 8/30/02 8/26/02 Xalatan (latanoprost) ophthalmic solution, 0.005%,-...
Prescription and Over-the-Counter Drug Product List: 1/2003 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACETAMINOPHEN; BUTALBITAL; CAFFEINE -A- SOLUTION; ORAL -A- ACETAMINOPHEN AND BUTALBITAL AND CAFFEINE -A- + MIKART 325MG/15ML;50MG/15ML;40MG/15ML N40387 001 JAN 31, 2003 JAN NEWA ACETAMINOPHEN; CODEINE PHOSPHATE TABLET; ORAL ACETAMINOPHEN AND CODEINE PHOSPAHTE -A- AA ANDRX PHARMS 300MG;15MG N40443 001 JAN 22, 2003 JAN NEWA -A- AA...
author: AUTHOR
http://www.fda.gov/cder/foi/appletter/2003/21434ltr.pdf DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration Rockville MD 20857 NDA 21- 434 Pharmacia & Upjohn Attention: Roma JXANAX ® XR (...
author: homonnaya
http://www.fda.gov/cder/foi/appletter/2003/21434ltr.pdf page 1
author: homonnaya
http://www.fda.gov/cder/foi/label/2003/21434_xanax_lbl.pdf FDA APPROVED LABELING FOR XANAX XR Attachment to FDA Approval Letter for NDA 21- 434 XANAX XR ™ brand of alprazolam extended- release tablets DESCRIPTION XANAX XR Tablets contain alprazolam which is a triazolo analog of the 1,4 benzodiazepine class of central nervous system- active compounds
http://www.fda.gov/cder/foi/label/2003/21434_xanax_lbl.pdf page 19
http://www.fda.gov/cder/foi/label/2003/21434_xanax_lbl.pdf page 17
http://www.fda.gov/cder/foi/label/2003/21434_xanax_lbl.pdf page 15
http://www.fda.gov/cder/foi/label/2003/21434_xanax_lbl.pdf page 11
http://www.fda.gov/cder/foi/label/2003/21434_xanax_lbl.pdf page 9
http://www.fda.gov/cder/foi/label/2003/21434_xanax_lbl.pdf page 8
http://www.fda.gov/cder/foi/label/2003/21434_xanax_lbl.pdf page 6
http://www.fda.gov/cder/foi/label/2003/21434_xanax_lbl.pdf page 5
http://www.fda.gov/cder/foi/label/2003/21434_xanax_lbl.pdf page 3
http://www.fda.gov/cder/foi/label/2003/21434_xanax_lbl.pdf page 2
http://www.fda.gov/cder/foi/label/2003/21434_xanax_lbl.pdf page 1
Vertigo: Dizziness and Vertigo: Merck Manual Home Edition Search Recent Searches Index Sections A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Accidents and Injuries Blood Disorders Bone, Joint, and Muscle Disorders Brain, Spinal Cord, and Nerve Disorders Cancer Children's Health Issues Digestive Disorders Disorders of Nutrition and Metabolism Drugs Ear, Nose, and Throat Disorders Eye Disorders Fundamentals Heart and Blood Vessel...
THE MERCK MANUAL OF GERIATRICS, App. III, Trade Names of Some Commonly Used Drugs, TACARYL to ZYPREXA Trade Names of Some Commonly Used Drugs TRADE AND GENERIC NAMES OF COMMONLY USED DRUGS TACARYL to ZYPREXA Trade Name Generic TACARYL Methdilazine TACE Chlorotrianisene TAGAMET Cimetidine TALWIN *Pentazocine TAMBOCOR Flecainide TAMIFLU Oseltamivir TAPAZOLE Methimazole TASMAR Tolcapone TAVIST Clemastine TAXOL Paclitaxel TAZICEF Ceftazidime TAZIDIME Ceftazidime TEGISON Etretinate...
THE MERCK MANUAL OF GERIATRICS, App. III, Trade Names of Some Commonly Used Drugs, Abciximab to Butorphanol Trade Names of Some Commonly Used Drugs GENERIC AND TRADE NAMES OF COMMONLY USED DRUGS Abciximab to Butorphanol Generic Trade Name Abciximab REOPRO Acarbose PRECOSE Acebutolol SECTRAL Acetaminophen TYLENOL Acetazolamide DIAMOX Acetohexamide DYMELOR Acetohydroxamic acid LITHOSTAT Acetophenazine TINDAL Acetylcysteine MUCOMYST ACTH See Corticotropin Acyclovir ZOVIRAX Adenosine ADENOCARD...
